Clinical Trial Update: Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab [NA]

View source ↗

Summary

A completed clinical trial evaluating circulating VE-cadherin as a biomarker in patients with metastatic colorectal cancer treated with bevacizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Centre Leon Berard | Conditions: Colorectal Cancer, Metastasis | NA | Status: COMPLETED